220 related articles for article (PubMed ID: 28795806)
1. Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP).
Abdel Monaim SAH; Ramchuran EJ; El-Faham A; Albericio F; de la Torre BG
J Med Chem; 2017 Sep; 60(17):7476-7482. PubMed ID: 28795806
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the N-Terminus Amino Function of Arg
Monaim SAHA; Noki S; Ramchuran EJ; El-Faham A; Albericio F; Torre BG
Molecules; 2017 Sep; 22(10):. PubMed ID: 28956840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine.
Jin K; Po KHL; Kong WY; Lo CH; Lo CW; Lam HY; Sirinimal A; Reuven JA; Chen S; Li X
Bioorg Med Chem; 2018 Mar; 26(5):1062-1068. PubMed ID: 29398444
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel teixobactin analogues.
Schumacher CE; Harris PWR; Ding XB; Krause B; Wright TH; Cook GM; Furkert DP; Brimble MA
Org Biomol Chem; 2017 Oct; 15(41):8755-8760. PubMed ID: 28993827
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and Biology of Teixobactin.
Guo C; Mandalapu D; Ji X; Gao J; Zhang Q
Chemistry; 2018 Apr; 24(21):5406-5422. PubMed ID: 28991382
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres.
Parmar A; Iyer A; Lloyd DG; Vincent CS; Prior SH; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2017 Jul; 53(55):7788-7791. PubMed ID: 28650495
[TBL] [Abstract][Full Text] [Related]
7. Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study.
Abdel Monaim SAH; Jad YE; El-Faham A; de la Torre BG; Albericio F
Bioorg Med Chem; 2018 Jun; 26(10):2788-2796. PubMed ID: 29029900
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation.
Jin K; Po KHL; Wang S; Reuven JA; Wai CN; Lau HT; Chan TH; Chen S; Li X
Bioorg Med Chem; 2017 Sep; 25(18):4990-4995. PubMed ID: 28495382
[TBL] [Abstract][Full Text] [Related]
9. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
Fiers WD; Craighead M; Singh I
ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
[TBL] [Abstract][Full Text] [Related]
10. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
[TBL] [Abstract][Full Text] [Related]
11. Multiple attack on bacteria by the new antibiotic teixobactin.
von Nussbaum F; Süssmuth RD
Angew Chem Int Ed Engl; 2015 Jun; 54(23):6684-6. PubMed ID: 25968231
[No Abstract] [Full Text] [Related]
12. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
[TBL] [Abstract][Full Text] [Related]
13. Defining the molecular structure of teixobactin analogues and understanding their role in antibacterial activities.
Parmar A; Prior SH; Iyer A; Vincent CS; Van Lysebetten D; Breukink E; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2017 Feb; 53(12):2016-2019. PubMed ID: 28124045
[TBL] [Abstract][Full Text] [Related]
14. Rational Design and Synthesis of Modified Teixobactin Analogues: In Vitro Antibacterial Activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa.
Ng V; Kuehne SA; Chan WC
Chemistry; 2018 Jun; 24(36):9136-9147. PubMed ID: 29741277
[TBL] [Abstract][Full Text] [Related]
15. Efficient total syntheses and biological activities of two teixobactin analogues.
Parmar A; Iyer A; Vincent CS; Van Lysebetten D; Prior SH; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2016 Apr; 52(36):6060-3. PubMed ID: 26984316
[TBL] [Abstract][Full Text] [Related]
16. The impact of backbone N-methylation on the structure-activity relationship of Leu
Velkov T; Swarbrick JD; Hussein MH; Schneider-Futschik EK; Hoyer D; Li J; Karas JA
J Pept Sci; 2019 Sep; 25(9):e3206. PubMed ID: 31389086
[TBL] [Abstract][Full Text] [Related]
17. Teixobactin: A Paving Stone toward a New Class of Antibiotics?
Gunjal VB; Thakare R; Chopra S; Reddy DS
J Med Chem; 2020 Nov; 63(21):12171-12195. PubMed ID: 32520557
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the Teixobactin Pharmacophore.
Yang H; Chen KH; Nowick JS
ACS Chem Biol; 2016 Jul; 11(7):1823-6. PubMed ID: 27232661
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
[TBL] [Abstract][Full Text] [Related]
20. Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance.
Qi YK; Tang X; Wei NN; Pang CJ; Du SS; Wang K
J Pept Sci; 2022 Nov; 28(11):e3428. PubMed ID: 35610021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
